Literature DB >> 24012919

Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling.

Elizabeth D Moore1, Mitra Kooshki2, Linda J Metheny-Barlow3, Patricia E Gallagher4, Mike E Robbins3.   

Abstract

About 500,000 new cancer patients will develop brain metastases in 2013. The primary treatment modality for these patients is partial or whole brain irradiation which leads to a progressive, irreversible cognitive impairment. Although the exact mechanisms behind this radiation-induced brain injury are unknown, neuroinflammation in glial populations is hypothesized to play a role. Blockers of the renin-angiotensin system (RAS) prevent radiation-induced cognitive impairment and modulate radiation-induced neuroinflammation. Recent studies suggest that RAS blockers may reduce inflammation by increasing endogenous concentrations of the anti-inflammatory heptapeptide angiotensin-(1-7) [Ang-(1-7)]. Ang-(1-7) binds to the AT(1-7) receptor and inhibits MAP kinase activity to prevent inflammation. This study describes the inflammatory response to radiation in astrocytes characterized by radiation-induced increases in (i) IL-1β and IL-6 gene expression; (ii) COX-2 and GFAP immunoreactivity; (iii) activation of AP-1 and NF-κB transcription factors; and (iv) PKCα, MEK, and ERK (MAP kinase) activation. Treatment with U-0126, a MEK inhibitor, demonstrates that this radiation-induced inflammation in astrocytes is mediated through the MAP kinase pathway. Ang-(1-7) inhibits radiation-induced inflammation, increases in PKCα, and MAP kinase pathway activation (phosphorylation of MEK and ERK). Additionally Ang-(1-7) treatment leads to an increase in dual specificity phosphatase 1 (DUSP1). Furthermore, treatment with sodium vanadate (Na3VO4), a phosphatase inhibitor, blocks Ang-(1-7) inhibition of radiation-induced inflammation and MAP kinase activation, suggesting that Ang-(1-7) alters phosphatase activity to inhibit radiation-induced inflammation. These data suggest that RAS blockers inhibit radiation-induced inflammation and prevent radiation-induced cognitive impairment not only by reducing Ang II but also by increasing Ang-(1-7) levels.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  ACEI; ARB; Ang; Angiotensin; Angiotensin converting enzyme inhibitor; Angiotensin receptor blocker; Angiotensin-(1–7); COX-2; Cyclooxygenase-2; DUSP1; Dual specificity phosphatase 1; EMSA; ERK; Electromobility-shift assay; Extracellular signal-regulated kinase; Fractionated whole brain irradiation; GFAP; Glial fibrillary acidic protein; IL; Interleukin; MAP kinase signaling; MEK; Mitogen-activated protein erk kinase; RAS; Radiation-induced Inflammation; Rat primary astrocytes; Renin-angiotensin system; TNF-α; Tumor necrosis factor-α; fWBI

Mesh:

Substances:

Year:  2013        PMID: 24012919      PMCID: PMC3879043          DOI: 10.1016/j.freeradbiomed.2013.08.183

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  55 in total

1.  Inflammatory blockade restores adult hippocampal neurogenesis.

Authors:  Michelle L Monje; Hiroki Toda; Theo D Palmer
Journal:  Science       Date:  2003-11-13       Impact factor: 47.728

2.  Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.

Authors:  Bhavani Krishnan; Thomas L Smith; Purnima Dubey; Michael E Zapadka; Frank M Torti; Mark C Willingham; E Ann Tallant; Patricia E Gallagher
Journal:  Prostate       Date:  2012-05-29       Impact factor: 4.104

3.  Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6.

Authors:  Luc Vallières; Iain L Campbell; Fred H Gage; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

4.  Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures.

Authors:  R F Regan; Y Wang; X Ma; A Chong; Y Guo
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

5.  Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury.

Authors:  Stephanos Kyrkanides; Amy H Moore; John A Olschowka; JoAnna C Daeschner; Jacqueline P Williams; John T Hansen; M Kerry O'Banion
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

Review 6.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Late cognitive and radiographic changes related to radiotherapy: initial prospective findings.

Authors:  C L Armstrong; J V Hunter; G E Ledakis; B Cohen; E M Tallent; B H Goldstein; Z Tochner; R Lustig; K D Judy; A Pruitt; J E Mollman; E M Stanczak; M Y Jo; T L Than; P Phillips
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

8.  The MEK/ERK pathway acts upstream of NF kappa B1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis.

Authors:  John F Kurland; David W Voehringer; Raymond E Meyn
Journal:  J Biol Chem       Date:  2003-06-11       Impact factor: 5.157

9.  Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.

Authors:  W Jeffrey Petty; Mebea Aklilu; Victor A Varela; James Lovato; Paul D Savage; Antonius A Miller
Journal:  BMC Cancer       Date:  2012-09-11       Impact factor: 4.430

10.  The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation.

Authors:  Caroline I Schnegg; Dana Greene-Schloesser; Mitra Kooshki; Valerie S Payne; Fang-Chi Hsu; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2013-03-14       Impact factor: 8.101

View more
  19 in total

1.  The phosphoinositide-3 kinase signaling is involved in neuroinflammation in hypertensive rats.

Authors:  Xing Tan; Pei-Lei Jiao; Yang-Kai Wang; Zhao-Tang Wu; Xiao-Rong Zeng; Miao-Ling Li; Wei-Zhong Wang
Journal:  CNS Neurosci Ther       Date:  2017-02-12       Impact factor: 5.243

Review 2.  Macrophages in neuroinflammation: role of the renin-angiotensin-system.

Authors:  Anna Hammer; Johannes Stegbauer; Ralf A Linker
Journal:  Pflugers Arch       Date:  2017-02-11       Impact factor: 3.657

Review 3.  Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

Authors:  Douglas M Bennion; Emily Haltigan; Robert W Regenhardt; U Muscha Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 4.  Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.

Authors:  Milan T Makale; Carrie R McDonald; Jona A Hattangadi-Gluth; Santosh Kesari
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

5.  Non-Human Primates Receiving High-Dose Total-Body Irradiation are at Risk of Developing Cerebrovascular Injury Years Postirradiation.

Authors:  Rachel N Andrews; Ethan G Bloomer; John D Olson; David B Hanbury; Gregory O Dugan; Christopher T Whitlow; J Mark Cline
Journal:  Radiat Res       Date:  2020-09-16       Impact factor: 2.841

6.  Impact of breathing 100% oxygen on radiation-induced cognitive impairment.

Authors:  Kenneth T Wheeler; Valerie Payne; Ralph B D'Agostino; Matthew C Walb; Michael T Munley; Linda J Metheny-Barlow; Mike E Robbins
Journal:  Radiat Res       Date:  2014-10-22       Impact factor: 2.841

7.  Chronic ANG II infusion induces sex-specific increases in renal T cells in Sprague-Dawley rats.

Authors:  Margaret A Zimmerman; Babak Baban; Ashlee J Tipton; Paul M O'Connor; Jennifer C Sullivan
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

Review 8.  The role of the renin-angiotensin system inhibitors in malignancy: a review.

Authors:  Ju Yang; Xi Yang; Ling Gao; Jie Zhang; Cheng Yi; Ying Huang
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

9.  Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.

Authors:  Ji C Bihl; Cheng Zhang; Yuhui Zhao; Xiang Xiao; Xiaotang Ma; Yusen Chen; Shuzhen Chen; Bin Zhao; Yanfang Chen
Journal:  Vascul Pharmacol       Date:  2015-08-08       Impact factor: 5.773

Review 10.  Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events.

Authors:  Matthias Pinter; Wilhelmus J Kwanten; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2018-04-02       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.